Hemostemix Inc (HEM) - Total Liabilities

Latest as of September 2025: CA$4.80 Million CAD ≈ $3.47 Million USD

Based on the latest financial reports, Hemostemix Inc (HEM) has total liabilities worth CA$4.80 Million CAD (≈ $3.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Hemostemix Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Hemostemix Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Hemostemix Inc's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Hemostemix Inc's assets to evaluate the company's liquid asset resilience ratio.

Hemostemix Inc Competitors by Total Liabilities

The table below lists competitors of Hemostemix Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Turnstone Biologics Corp. Common Stock NASDAQ:TSBX	USA	$6.34 Million
NRB Industrial Bearings Limited NSE:NIBL	India	Rs1.76 Billion
Northann Corp. NYSE MKT:NCL	USA	$11.43 Million
Puri Global Sukses Tbk Pt JK:PURI	Indonesia	Rp428.63 Billion
Shanghai Broadband Technology Co Ltd SHG:600608	China	CN¥61.81 Million
Crown Point Energy Inc V:CWV	Canada	CA$211.06 Million
Natural Health Trends Corp F:NAH	Germany	€15.49 Million
Aumake Ltd AU:AUK	Australia	AU$4.53 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Hemostemix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Hemostemix Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.54	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	3.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hemostemix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hemostemix Inc (2013–2024)

The table below shows the annual total liabilities of Hemostemix Inc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$8.20 Million ≈ $5.93 Million	+6.65%
2023-12-31	CA$7.68 Million ≈ $5.56 Million	+6.23%
2022-12-31	CA$7.23 Million ≈ $5.23 Million	+23.73%
2021-12-31	CA$5.85 Million ≈ $4.23 Million	+70.87%
2020-12-31	CA$3.42 Million ≈ $2.48 Million	-17.54%
2019-12-31	CA$4.15 Million ≈ $3.00 Million	+253.31%
2018-12-31	CA$1.17 Million ≈ $849.58K	+152.68%
2017-12-31	CA$464.79K ≈ $336.22K	-87.40%
2016-12-31	CA$3.69 Million ≈ $2.67 Million	+492.45%
2015-12-31	CA$622.73K ≈ $450.47K	+12.87%
2014-12-31	CA$551.70K ≈ $399.09K	+127.05%
2013-12-31	CA$242.98K ≈ $175.77K	--

About Hemostemix Inc

V:HEM Canada Biotechnology

Market Cap

$8.18 Million

CA$11.31 Million CAD

Market Cap Rank

#27575 Global

#1169 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.05 - CA$0.12

All Time High

CA$13.40